Heide, Germany

Jan Christoph Reich

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Annexin Pharmaceuticals Ab. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Christoph Reich. Retrieved from https://idiyas.com/inventor/jan-christoph-reich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jan Christoph Reich: Innovator in Protein Recovery Processes

Introduction

Jan Christoph Reich is a notable inventor based in Heide, Germany. He has made significant contributions to the field of biochemistry, particularly in the recovery and purification of intracellular proteins. With a total of 2 patents, his work has implications for various applications in pharmaceuticals and biotechnology.

Latest Patents

Reich's latest patents focus on the process of manufacturing annexin V. The first patent describes a method for recovering and purifying a recombinantly expressed intracellular protein, specifically Annexin A5 (AnxA5), from an endotoxin-producing host cell. This innovative process involves releasing the intracellular protein from the host cell using a homogenization buffer that contains non-ionic detergent. Notably, the method does not require any centrifugation steps for the recovery and purification of the AnxA5 protein after its release. The AnxA5 protein remains in solution throughout the process, except when temporarily bound to chromatographic resins.

Career Highlights

Jan Christoph Reich is currently associated with Annexin Pharmaceuticals AB, where he continues to advance his research in protein recovery techniques. His expertise in this area has positioned him as a valuable contributor to the field.

Collaborations

Reich collaborates with Toomas Moks, further enhancing the innovative work being done at Annexin Pharmaceuticals AB.

Conclusion

Jan Christoph Reich's contributions to the field of protein recovery and purification are noteworthy. His innovative processes have the potential to impact the pharmaceutical industry significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…